Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
Johnson & Johnson survey finds AI use rising in community oncology but implementation barriers remain
FDA approves shorter monitoring period for first two doses of Amgen’s Imdelltra
Eli Lilly finalizes purchase of AtaiBeckley, expanding its pipeline for treatment-resistant depression and other mental health conditions
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Overcoming Downstream Bottlenecks In The Upscaling Process
Presented by Dr. Dakshesh Mehta, Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center
17th January 2019
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
Analytical Strategies for Comparability in Bioprocess Development
Presented by Dr Christine P. Chan, Director in Global Manufacturing Science & Technology at Sanofi
15th September 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Amsphere TM A3
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
